InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,451.68
(
0.07%
)
US TECH 100
19,121.60
(
0.86%
)
Dow Jones
39,000.97
(
-1.04%
)
Brent Oil
84.38
(
-1.05%
)
Bitcoin
61,482.16
(
2.02%
)
Post# of 462416
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

A_Good_Day_2

Send PM Follow Ignore
Followers 4
Posts 702
Boards Moderated 0
Alias Born 05/19/2016

A_Good_Day_2

Re: tredenwater2 post# 81774

Friday, 12/02/2016 6:16:37 PM

Friday, December 02, 2016 6:16:37 PM

Post# of 462416
Biogen is currently enrolling for a phase 3 AD study. What are the chances that they run a dual trial of some kind? Administer their drug to remove plaque, and simultaneously administer 2-73 to fix the cells and prevent more damage.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM

Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM

Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM

Start posting your company's news
Only $200 per official company press release!